Impact of spatial metabolomics on immune-microenvironment in oral cancer prognosis: a clinical report

Authors:

Abstract
MALDI imaging for metabolites and immunohistochemistry for 38 immune markers was used to characterize the spatial biology of 2 primary oral tumours, one from a patient with an early recurrence (Tumour R), and the other from a patient with no recurrence 2 years after treatment completion (Tumour NR). Tumour R had an increased purine nucleotide metabolism in different regions of tumour and adenosine-mediated suppression of immune cells compared to Tumour NR. The differentially expressed markers in the different spatial locations in tumour R were CD33, CD163, TGF-β, COX2, PD-L1, CD8 and CD20. These results suggest that altered tumour metabolomics concomitant with a modified immune microenvironment could be a potential marker of recurrence.
Funding Information
  • Department of Biotechnology, Ministry of Science and Technology, India (No./BT/Med-II/NIBMG/SyMeC/2014/Vol II).)

This publication has 29 references indexed in Scilit: